Is Organon & Co Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NYSE: OGN) stock is to Buy OGN stock.
Out of 2 analysts, 0 (0%) are recommending OGN as a Strong Buy, 1 (50%) are recommending OGN as a Buy, 1 (50%) are recommending OGN as a Hold, 0 (0%) are recommending OGN as a Sell, and 0 (0%) are recommending OGN as a Strong Sell.
What is OGN's forecast return on equity (ROE) for 2023-2026?
(NYSE: OGN) forecast ROE is N/A, which is considered weak.
What is OGN's Price Target?
According to 2 Wall Street analysts that have issued a 1 year OGN price target, the average OGN price target is $29.00, with the highest OGN stock price forecast at $33.00 and the lowest OGN stock price forecast at $25.00.
On average, Wall Street analysts predict that Organon & Co's share price could reach $29.00 by May 8, 2024. The average Organon & Co stock price prediction forecasts a potential upside of 46.76% from the current OGN share price of $19.76.
What is OGN's forecast return on assets (ROA) for 2023-2026?
(NYSE: OGN) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - General industry average of 5.9%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.